Main Menu

Professor Nicola Valeri

Team Leader

The alt text
Professor Valeri is a Clinician/Scientist working to discover novel therapeutic targets and novel biomarkers for gastrointestinal cancers. He leads the Gastrointestinal Cancer Biology and Genomics Team within the Centre for Molecular Pathology at the ICR. Team: Gastrointestinal Cancer Biology and Genomics
+44 20 8722 4311 ORCID 0000-0002-5426-5683


Professor Nicola Valeri is interested in the study of gastrointestinal cancers with a special focus on colorectal and gastro-oesophageal cancers. Research in Nicola’s Lab is moving in three main directions:

1) Studying circulating microRNAs as predictors or response in gastrointestinal cancer patients;

2) Using large scale RNAi screenings to define novel therapeutic targets;

3) Developing novel pre-clinical models for drug testing and study mechanisms of resistance.

See all news stories on our website that feature the work of Professor Valeri and colleagues.

Read news

Nicola received his medical training in Italy where he completed his residency and fellowship in Medical Oncology in 2008. After spending his last year of training in the States Nicola was captivated by the promises and challenges of microRNAs research and went on to undertake his Research Fellowship in Professor Croce’s Lab investigating the role of non-coding RNAs in gastrointestinal cancers.

After five years in the States, Professor Valeri moved to Glasgow University as Clinical Lecturer in 2012 and he was then promoted Senior Clinical Lecturer in Medical Oncology at the beginning of 2013. He was appointed as one of the new Team Leaders at the Centre of Molecular Pathology in October 2013.

Professor Valeri received several prestigious awards including the American-Italian Cancer Foundation International Fellowship (2008-2010), The Italian Foundation for Cancer Research Fellowship for Research Abroad (2010), The Sidney Kimmel Translational Scholar Award (2010-2012) and the Medical Research Society Prize at the Academy of Medical Sciences Clinician Scientist Spring Meeting (2013).

Research in Nicola’s Lab is currently funded by ICR Institutional Funding, Cancer Research UK and the European Commission Research Executive Agency.